Tower Research Capital (TRC)’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $78.8K | Buy |
36,834
+28,407
| +337% | +$60.8K | ﹤0.01% | 2575 |
|
2025
Q1 | $9.69K | Buy |
8,427
+519
| +7% | +$597 | ﹤0.01% | 3742 |
|
2024
Q4 | $17.3K | Sell |
7,908
-794
| -9% | -$1.74K | ﹤0.01% | 3314 |
|
2024
Q3 | $19K | Sell |
8,702
-3,356
| -28% | -$7.32K | ﹤0.01% | 3267 |
|
2024
Q2 | $27.9K | Sell |
12,058
-2,647
| -18% | -$6.12K | ﹤0.01% | 3543 |
|
2024
Q1 | $80.9K | Sell |
14,705
-5,222
| -26% | -$28.7K | ﹤0.01% | 1955 |
|
2023
Q4 | $49.2K | Buy |
19,927
+18,620
| +1,425% | +$46K | ﹤0.01% | 3144 |
|
2023
Q3 | $45.4K | Buy |
1,307
+634
| +94% | +$22K | ﹤0.01% | 2625 |
|
2023
Q2 | $22.1K | Buy |
673
+229
| +52% | +$7.51K | ﹤0.01% | 3278 |
|
2023
Q1 | $15K | Sell |
444
-62
| -12% | -$2.1K | ﹤0.01% | 3827 |
|
2022
Q4 | $16K | Sell |
506
-1,490
| -75% | -$47.1K | ﹤0.01% | 3382 |
|
2022
Q3 | $70K | Buy |
1,996
+183
| +10% | +$6.42K | ﹤0.01% | 2867 |
|
2022
Q2 | $22K | Buy |
1,813
+852
| +89% | +$10.3K | ﹤0.01% | 3710 |
|
2022
Q1 | $13K | Buy |
961
+414
| +76% | +$5.6K | ﹤0.01% | 4006 |
|
2021
Q4 | $11K | Buy |
+547
| New | +$11K | ﹤0.01% | 4465 |
|